FirstRanker Logo

FirstRanker.com - FirstRanker's Choice is a hub of Question Papers & Study Materials for B-Tech, B.E, M-Tech, MCA, M.Sc, MBBS, BDS, MBA, B.Sc, Degree, B.Sc Nursing, B-Pharmacy, D-Pharmacy, MD, Medical, Dental, Engineering students. All services of FirstRanker.com are FREE

📱

Get the MBBS Question Bank Android App

Access previous years' papers, solved question papers, notes, and more on the go!

Install From Play Store

Download MBBS Surgery Presentations 25 Haemostasis Lecture Notes

Download MBBS (Bachelor of Medicine, Bachelor of Surgery) 1st Year, 2nd Year, 3rd Year and Final year Surgery 25 Haemostasis PPT-Powerpoint Presentations and lecture notes

This post was last modified on 08 April 2022

--- Content provided by​ FirstRanker.com ---


`THE DOCTOR WAS IN SUCH A HURRY TO OPERATE ON MY FATHER,

LIKE A CHILD WANTING A LOLLYPOP'
When an incision is made , the blood clots

--- Content provided by‌ FirstRanker.com ---


A 68 year old woman with a history of a 12 kg weight loss over the past

six months presents to the emergency room with a history of passing

--- Content provided by‌ FirstRanker.com ---

bright red blood per rectum. Her pulse is 95, her blood pressure 120/70.

She has not seen a physician in 40 years.

Study Questions:

--- Content provided by‌ FirstRanker.com ---

What history and physical exam information would you gather to assess

this patient's coagulation system?

If there is a problem present, what would be the most likely?

--- Content provided by FirstRanker.com ---

What laboratory tests would you order to assess this patient's

coagulation system?
A 24 year old man is in the operating room for a massive liver injury

--- Content provided by​ FirstRanker.com ---

sustained when his motorcycle hit a truck. After one hour of surgery he

has received 15 units of packed cells and has developed diffuse oozing

from the surface of his liver. Clots are no longer forming. His body

--- Content provided by​ FirstRanker.com ---


temperature is 34oC.

Study Question:
What are the most common coagulation difficulties associated with

--- Content provided by‍ FirstRanker.com ---


massive transfusion? What is the management of each?

HAEMOSTASIS
OBJECTIVES

--- Content provided by‌ FirstRanker.com ---


Mechanism of coagulation

Tests

--- Content provided by​ FirstRanker.com ---

Abnormal thrombosis

Abnormal bleeding

HAEMOSTASIS

--- Content provided by​ FirstRanker.com ---


Keeps blood in fluid state & in circulation

Prevents blood loss
Haemostasis

--- Content provided by‍ FirstRanker.com ---


Four interconnected mechanisms form the basis of hemostasis:
(a) blood vessel contraction
(b) platelet plug formation (primary hemostasis)
(c) clot stabilization with fibrin cross-linking (secondary hemostasis)

--- Content provided by⁠ FirstRanker.com ---

(d) endogenous fibrinolysis.

What is involved in

Haemostasis?

--- Content provided by‍ FirstRanker.com ---


Blood vessels
Platelets
Plasma coagulation factors
Inhibitors

--- Content provided by FirstRanker.com ---

Fibrinolytics
Events in Haemostasis

Vascular spasm
Formation of platelet plug

--- Content provided by⁠ FirstRanker.com ---

Formation of fibrin plug - Blood clot
Re-establishment of endothelium

Haemostasis

--- Content provided by‌ FirstRanker.com ---

Vasoconstriction

Clean cut vessels > crushed vessels
Partially transected > completely cut
Veins are easily compressed

--- Content provided by FirstRanker.com ---

Danger areas of bleed
Haemostasis

Platelet plug - White bodies or microthrombi
Contact with subendothelial collagen

--- Content provided by‌ FirstRanker.com ---

swell
irregular with pseudopods
release ADP, thromboxane A2 , phospholipids , HMWK
sticky & aggregate

--- Content provided by FirstRanker.com ---

Haemostasis

Fibrin clot:
Severe trauma - 15-20 secs

--- Content provided by‌ FirstRanker.com ---

Minor trauma - 1-2 mts

Retraction - 20-60 mts
Haemostasis

--- Content provided by‌ FirstRanker.com ---

COAGULATION

3 steps:
Prothrombin activator

--- Content provided by‌ FirstRanker.com ---

Prothrombin Thrombin

Fibrinogen Fibrin

Haemostasis

--- Content provided by⁠ FirstRanker.com ---


Pathways

Intrinsic - XI = slow

--- Content provided by​ FirstRanker.com ---

Extrinsic - VII = fast

Common pathway
factor V
Xa Prothrombin activator

--- Content provided by⁠ FirstRanker.com ---

phospholipid, calcium
Haemostasis

Extrinsic

--- Content provided by FirstRanker.com ---

Tissue extract factor VII factor X

Intrinsic

surface contact VI

--- Content provided by‌ FirstRanker.com ---

XI XI a XI a IX a X
HMWK phospholipid

calcium

--- Content provided by​ FirstRanker.com ---



BOTH ARE ESSENTIAL

HAEMOSTASIS

--- Content provided by​ FirstRanker.com ---


ACTIVATED PLATELETS

Prothrombin activator {rate limiting factor}
{THROMBOPLASTIN}

--- Content provided by‍ FirstRanker.com ---


CALCIUM
PROTHROMBIN THROMBIN

FIBRINOGEN FIBRIN MONOMERS

--- Content provided by FirstRanker.com ---

CALCIUM XII

FIBRIN POLYMERS STABLE

CLOT

--- Content provided by⁠ FirstRanker.com ---

HAEMOSTASIS

PRODUCTION OF CLOTTING FACTORS
Fibrinogen liver
I , VII, IX, X liver with vit K

--- Content provided by⁠ FirstRanker.com ---

VII , V, XI endothelium
XI I platelets

HAEMOSTASIS

--- Content provided by FirstRanker.com ---

THROMBIN

Intensely proteolytic
Activates factor V ,VII , XI I
Releases phospholipid from endothelium & platelet

--- Content provided by FirstRanker.com ---

Activates protein C




--- Content provided by‌ FirstRanker.com ---

HAEMOSTASISCONTROL

Fibrinolysin or Plasmin
Plasminogen activator

--- Content provided by⁠ FirstRanker.com ---

DIGESTS

ACTIVATES

fibrin

--- Content provided by‌ FirstRanker.com ---


factor XII

fibrinogen kinin
factor VI complement

--- Content provided by⁠ FirstRanker.com ---

factor V,XII
prothrombin

Inhibited by- alpha 2 plasmin inhibitor .

--- Content provided by‌ FirstRanker.com ---

HAEMOSTASIS

Why does not blood clot normally ?

Endothelium

--- Content provided by FirstRanker.com ---


Fibrin & Antithrombin

smooth

--- Content provided by⁠ FirstRanker.com ---

thrombin fibrin [85-90%]

glycocalyx antithrombin
thrombomodulin
prostacyclin

--- Content provided by​ FirstRanker.com ---

heparin sulfate
tissue plasminogen activator
ADP ase
HAEMOSTASIS

--- Content provided by⁠ FirstRanker.com ---

Why does not blood clot normally?
Heparin Thrombin
Alpha 2 macroglobulin Thrombin
C 1 inhibitor XI a, Kallikrein
Alpha 1 antitrypsin XI a, Elastase

--- Content provided by FirstRanker.com ---

Protein C Va, VII a

Tests of blood coagulation

1. Bleeding time:

--- Content provided by​ FirstRanker.com ---


2.Clotting time:

{modified Ivy's method}

--- Content provided by​ FirstRanker.com ---

{Lee & White method}

N = 1-6 mts

N = 6-10 mts in glass

--- Content provided by⁠ FirstRanker.com ---


platelet plug

N = 20-60 mts in

--- Content provided by‌ FirstRanker.com ---

Prolonged in:

siliconized tubes

Thrombocytopenia

--- Content provided by​ FirstRanker.com ---


Measures intrinsic &

Thrombasthenia

--- Content provided by FirstRanker.com ---

common pathway

Von-Wil ebrand's disease
Tests of blood coagulation

--- Content provided by FirstRanker.com ---

Prothrombin time: { Quick's one stage test }


calcium

--- Content provided by⁠ FirstRanker.com ---

oxalated blood from patient

clot

tissue thromboplastin

--- Content provided by‌ FirstRanker.com ---


N = 12 secs

extrinsic & common pathway

--- Content provided by‌ FirstRanker.com ---

Prothrombin time contd. .

Prolonged in:
1. Oral anticoagulant drugs
2. Liver disease, obstructive jaundice

--- Content provided by⁠ FirstRanker.com ---

3. Vit K deficiency
4. D I C
5. Deficiency of factor VI , X, V, II
SPECIFIC FOR FACTOR VII
[ With X & V APTT is also prolonged]

--- Content provided by⁠ FirstRanker.com ---

PARTIAL THROMBOPLASTIN TIME

[ activated ]

Contact activation

--- Content provided by‍ FirstRanker.com ---


KAOLIN
+

of factor XI + pt's = Clot

--- Content provided by​ FirstRanker.com ---


CEPHALIN

blood

--- Content provided by​ FirstRanker.com ---

phospholipid

Intrinsic & Common pathway

Partial thromboplastin time

--- Content provided by⁠ FirstRanker.com ---


[activated ] contd.....

Prolonged in:
1. D I C

--- Content provided by FirstRanker.com ---

2. Liver disease
3. Massive transfusion of stored blood
4. Heparin
5. Circulating anticoagulants
6. Deficiency of clotting factors other than VI

--- Content provided by​ FirstRanker.com ---

7. Haemophilia
THROMBIN TIME

PLASMA + THROMBIN CLOT
Assesses fibrinogen

--- Content provided by⁠ FirstRanker.com ---

Prolonged in :
1. Hypofibrinogenemia

DIC CONGENITAL
2. FDP

--- Content provided by⁠ FirstRanker.com ---

3. Heparin [ assess with REPTILASE test ]
4. Dysfibrinogenaemia

PLATELET COUNT

--- Content provided by‌ FirstRanker.com ---

N = 150 - 300 x 10 9 / L
80 x 10 9 / L Bleeding may fol ow trauma
< 40 x 10 9 / L Spontaneous haemorrhage
< 10 x 10 9 / L Lethal haemorrhage
PRIMARY SCREENING TESTS

--- Content provided by⁠ FirstRanker.com ---


Bleeding time
Platelet count
P T
A P T T

--- Content provided by‍ FirstRanker.com ---


Specific tests- Factor VII , XI I, fibrinogen
Tests for fibrinolysis

ABNORMAL HAEMOSTASIS

--- Content provided by‍ FirstRanker.com ---


Normal haemostasis

PT

--- Content provided by FirstRanker.com ---

APTT TT

Platelet count Disorder of platelet

function.

--- Content provided by‍ FirstRanker.com ---


1 n

n

--- Content provided by‍ FirstRanker.com ---

n

n

Mild coagulation

--- Content provided by‌ FirstRanker.com ---

disorder

Factor VII deficiency

2 long

--- Content provided by​ FirstRanker.com ---


n

n

--- Content provided by‍ FirstRanker.com ---

n

Early oral
Anticoagulation
12-36 hrs

--- Content provided by FirstRanker.com ---


3 n

long

--- Content provided by FirstRanker.com ---

n

n

Factor VII , IX, XI, XI deficiency

--- Content provided by FirstRanker.com ---

Prekal ikrein, HMWK
Deficiency, vWD,
circulating
anticoagulant
ABNORMAL HAEMOSTASIS

--- Content provided by‌ FirstRanker.com ---


PT

APTT TT

--- Content provided by‍ FirstRanker.com ---

Platelet

count

Vit K deficiency

--- Content provided by‌ FirstRanker.com ---

Oral anticoagulants

4 long

long

--- Content provided by‍ FirstRanker.com ---


n

N

--- Content provided by​ FirstRanker.com ---

Heparin, Fibrinogen

5 long

long

--- Content provided by​ FirstRanker.com ---


long

N

--- Content provided by⁠ FirstRanker.com ---

Deficiency, Liver
disease, Fibrinolysis

6 n

--- Content provided by‌ FirstRanker.com ---

n

n

Low

--- Content provided by⁠ FirstRanker.com ---


Thrombocytopenia

7 long

--- Content provided by‌ FirstRanker.com ---

long

n

Low

--- Content provided by⁠ FirstRanker.com ---


Massive transfusion
Liver disease

8 long

--- Content provided by FirstRanker.com ---


long

long

--- Content provided by​ FirstRanker.com ---

low

DIC

SURGICAL SCREENING

--- Content provided by⁠ FirstRanker.com ---

HAEMOSTASIS

In a patient who bleeds:

LIVER

--- Content provided by⁠ FirstRanker.com ---

IMMUNOLOGIC
RENAL

COMPLETE

--- Content provided by FirstRanker.com ---

CARDIAC

WORK UP

SEVERE INFECTION

--- Content provided by‍ FirstRanker.com ---

DRUGS

Best screening test - HISTORY

NATURAL ANTICOAGULANTS

--- Content provided by‍ FirstRanker.com ---


Antithrombin II
Protein C and protein S
NATURAL ANTICOAGULANTS

--- Content provided by‌ FirstRanker.com ---

Antithrombin II
This is an inhibitor of thrombin, its action being potentiated by heparin.
Congenital antithrombin II deficiency is inherited as an autosomal

dominant.

--- Content provided by‌ FirstRanker.com ---


Heterozygotes may suffer from recurrent DVT, pulmonary embolism,

and mesenteric thrombosis.

--- Content provided by‍ FirstRanker.com ---

Homozygotes present in childhood with severe arterial and venous

thrombosis.

NATURAL ANTICOAGULANTS

--- Content provided by‌ FirstRanker.com ---


Protein C and protein S
These are synthesised in the liver and are dependant on vitamin K.
Protein C degrades factors Va and VII a and promotes fibrinolysis by

--- Content provided by‍ FirstRanker.com ---

inactivating plasminogen-activator inhibitor I.

Protein S is a cofactor for protein C and enhances its activity.
Hereditary protein C defciency may occur, patients being more

--- Content provided by⁠ FirstRanker.com ---

susceptible to DVT, PE, superficial thrombophlebitis, and cerebral

venous thrombosis
ANTICOAGULANT DRUGS

--- Content provided by​ FirstRanker.com ---

Warfarin
Warfarin is a coumarin derivative which is administered orally.
It is a vitamin K antagonist and in effect induces a state analogous to

vitamin K deficiency.

--- Content provided by‌ FirstRanker.com ---


It interferes with the activity of factors II, VII, IX and X. It delays

thrombin generation, thus preventing the formation of thrombi.

--- Content provided by FirstRanker.com ---

Warfarin is usually administered for 3?6 months following DVT or PE
Lifelong warfarin is required for recurrent venous thromboembolic

disease,some prosthetic heart valves, congenital deficiency of

--- Content provided by​ FirstRanker.com ---

antithrombin II , deficiency of protein C or protein S,

ANTICOAGULANT DRUGS

Heparin

--- Content provided by⁠ FirstRanker.com ---

Heparin potentiates the action of antithrombin I I.
Standard unfractionated heparin is administered i.v. or s.c. and has a half

life of about 1 h.

--- Content provided by‌ FirstRanker.com ---

Low molecular weight heparin is used subcutaneously and has a longer

biological half life.

Heparin does not cross the placenta and is, therefore, the drug of choice

--- Content provided by FirstRanker.com ---


when anticoagulation is required during pregnancy.

Bleeding due to overdose is managed by stopping the heparin and

--- Content provided by‌ FirstRanker.com ---

administering protamine sulphate intravenously.

Side effects of heparin include thrombocytopaenia,hypersensitivity

reactions, alopecia, and osteoporoi

--- Content provided by‌ FirstRanker.com ---

DISORDERS OF

HAEMOSTASIS AND

COAGULATION

--- Content provided by​ FirstRanker.com ---


CONGENITAL

HAEMOPHILIA A and B.
Von WILLEBRAND'S disease.

--- Content provided by‍ FirstRanker.com ---

Defencies of factorXI and XI ,prekallikrien,HMWkininogen.
Defencies of factorVII,V and thrombin.
Disorders of fibrinogen like a or hypofibrinogenemia or

dysfibrinogenemia.

--- Content provided by‍ FirstRanker.com ---


Factor XI I defeciency.
ACQUIRED

VITAMIN K DEFECIENCY.

--- Content provided by FirstRanker.com ---

ANTICOAGULANT DRUGS.
HEPATIC FAILURE.
RENAL FAILURE.
THROMBOCYTOPENIA.
THROMBOCYTOPATHY.

--- Content provided by FirstRanker.com ---

HYPOTHERMIA.
DIC.

APPROACH
HISTORY

--- Content provided by⁠ FirstRanker.com ---


H\O bleeding,easybruising.
Frequent or unusual mucosal bleeding.
Metromenorrahgia.
Haematuria.

--- Content provided by⁠ FirstRanker.com ---

Epistaxis.
Previous h\o prolonged bleeding asso with invasive procedures.
Positive family history.
Drug history like intake of NSAIDS,aspirin,etc.

--- Content provided by FirstRanker.com ---

EXAMINATION

Ecchymotic patches or petechiae on skin.
Joint deformities.
Adenopathy.

--- Content provided by​ FirstRanker.com ---

Hepatospleenomegaly.
Hypermobility of joints.
Increased elaticity of skin.
SCREENING TESTS

--- Content provided by‌ FirstRanker.com ---

CBC.
Platelet count.
PT.
aPTT.
Bleeding time.

--- Content provided by‍ FirstRanker.com ---

Fibrinogen level.
Thrombin time.
Platelet function tests.
Specific factor assays.

--- Content provided by‌ FirstRanker.com ---

PROTHROMBIN TIME

Measures function of factor VII,X, prothrombin and thrombin,fibrinogen

and fibrin.

--- Content provided by​ FirstRanker.com ---


Prolongation occurs when levels of factor V,VII or X fall.
Seen in warfarin therapy and vit.k defeciency.
aPTT

--- Content provided by FirstRanker.com ---

Detects decreased levels ofHMWkininogen,prekallikrien,XI ,XI,IX,VII ,V,X.
Increased in heparin therapy.

CONGENITAL

--- Content provided by‌ FirstRanker.com ---

DISORDERS
HAEMOPHILIA A
HAEMOPHILIA A

Deficiency of factor VII .

--- Content provided by FirstRanker.com ---

X linked recessive disorder with males being affected exclusively.
Severe bleeding if factor level<2%.Moderate bleeding with levels b\w

2%-5%.Mild bleeding with factor levels b\w 5%-30%.

--- Content provided by‍ FirstRanker.com ---

Patient has large haematomas and haemarthroses.
Bleeding is prolonged for hours or days after injury.
Lab tests show a prolonged Aptt with decreased factor VII level,normal

PT,bleeding time and vWF levels.

--- Content provided by‌ FirstRanker.com ---


HAEMOPHILIA A

Desmopressin may temporarily raise factor VII levels in mild disease.
Can be given intranasal y or iv and is ineffective in treating severe disease.

--- Content provided by‌ FirstRanker.com ---

Antifibrinolytic therapy with EACA and tranexemic acid with or without

desmopressin is also effective in dental extarctions or paediatric patients.

CRYOPRECIPITATE is a good source of factorVII .

--- Content provided by FirstRanker.com ---

One bag contains 80 units of factor VII and 1U\kg increases levels by2%.
Specific factor VII concentrates are more popular now.
Give 50U\kg stat then 30U\kg every 8 hrs for the first 2 days after surgery

or injury.

--- Content provided by FirstRanker.com ---

CONGENITAL

DISORDERS
HAEMOPHILIA B

--- Content provided by⁠ FirstRanker.com ---

HAEMOPHILIA B

Xlinked bleeding disorder with a deficiency of factor IX.
Patient presents with deep bleeding and haemarthroses.
Lab tests show increased Aptt with decreased factor IX levels, normal

--- Content provided by‌ FirstRanker.com ---


PT, BT,platelet count and factor VII .

Tt is by prothrombin complex concentrate which contains factor IX and

--- Content provided by⁠ FirstRanker.com ---

all of the vit k dependent factors.

HighPurity factor IX concentrate is also available.
CONGENITAL

--- Content provided by FirstRanker.com ---

DISORDERS
VON WILLEBRAND'S DISEASE

Von WILLEBRAND'S DISEASE

--- Content provided by FirstRanker.com ---

Most common congenital bleeding disorder.
vWF is an important stimulus for platelet aggregation and carrier

protien for factor VII .

--- Content provided by‌ FirstRanker.com ---

Type 1 is inherited as autosomal dominant and is characterized by

quantitative defect in vWF.

Type 2 has variable inheritance and there is qualitative defect in vWF.

--- Content provided by​ FirstRanker.com ---

Type3 is autosomal recessive disease with absent levels of vWF.
Patients present with mucosal bleeding,petechiae,epistaxis and

menorrhagia.

--- Content provided by‌ FirstRanker.com ---

Tt is by desmopressin or cryoprecipitate.
ACQUIRED

DISORDERS
VITAMIN K DEFECIENCY

--- Content provided by‍ FirstRanker.com ---


Platelet disorders

Thrombocytopaenia
This may be due to a failure of platelet production or increased

--- Content provided by‌ FirstRanker.com ---


destruction or sequestration of platelets, and abnormal platelet

function.

--- Content provided by‍ FirstRanker.com ---

Abnormal platelet function may cause bleeding despite a normal

platelet count.

Abnormal platelet function may occur with: drugs, e.g. aspirin, non-

--- Content provided by​ FirstRanker.com ---


steroidal antiinflammatory drugs carbenicillin, and ticarcillin;

uraemia;septicaemia; and von Willebrand's disease.
Blood vessel wal

--- Content provided by‍ FirstRanker.com ---


abnormalities

Blood vessel wal abnormalities
These are rare and may be due to scurvy, steroids, Cushing's syndrome,

--- Content provided by‌ FirstRanker.com ---


or Henoch-Schonlein purpura.

VITAMIN K DEFICIENCY

--- Content provided by​ FirstRanker.com ---

Vit k is required for the reaction that attaches a carboxyl gp to glutamic

acid.

Causes of def are inadequate dietary intake,

--- Content provided by⁠ FirstRanker.com ---

Malabsorption,obstructive jaundice,biliaryfistula,
Oral antibiotics and TPN.
Tt is parenteral administration of vit k if there is no active bleeding.
Administration of FFP rapidly corrects the coagulation deficit and is

--- Content provided by‌ FirstRanker.com ---

given in patients with ongoing bleeding.

Correction of the etiology.
ACQUIRED

--- Content provided by⁠ FirstRanker.com ---

DISORDERS
HEPATIC INSUFFICIENCY

HEPATIC INSUFFICIENCY

--- Content provided by‌ FirstRanker.com ---

Liver is the site of synthesis of all clotting factors except factorVII ,vWF.
Hepatic failure will result in coagulopathy.
Asso with platelet dysfunction.
Tt is by giving vitk,FFP,cryoprecipitate and platelets.
ACQUIRED

--- Content provided by FirstRanker.com ---


DISORDERS
HYPOTHERMIA

HYPOTHERMIA

--- Content provided by FirstRanker.com ---


Usually seen in a lengthy open surgery on the abdomen or thorax.
The coagulopathy is because of defect in platelet function,fibrinolytic

activity,coagulation cascade enzyme.

--- Content provided by FirstRanker.com ---


Intraoperatively all efforts should be made to keep the temp normal by

warming fluids,heated ventilation and warm environment.
ACQUIRED

--- Content provided by​ FirstRanker.com ---


DISORDERS
MASSIVE TRANSFUSION

MASSIVE TRANSFUSION

--- Content provided by​ FirstRanker.com ---


Defined as more than 10 units of transfused blood or replacement of

the pts total blood volume within 24 hrs.

--- Content provided by‌ FirstRanker.com ---

Pts have thrombocytopenia,low fibrinogen and prolonged PT.
These changes result from low temperature of blood,increased citrate

level,increased k level,low pH,decreased ca level.

--- Content provided by‌ FirstRanker.com ---

Tt is by infusion of FFP,PLATELETS.
POST-OP THROMBOSIS

WHY?

--- Content provided by⁠ FirstRanker.com ---

1. NO MUSCLE CONTRACTION

2. FIBRINOGEN , PLATELET,vWF, FACTOR VII

3. DECREASED ANTITHROMBIN I I

--- Content provided by‌ FirstRanker.com ---


4. SEPSIS

5. DAMAGE TO VEINS

--- Content provided by⁠ FirstRanker.com ---

POST-OP THROMBOSIS

PREVENTION:
Intermittent compression or electrical stimulation
Aspirin, dextran, di-pyridamole

--- Content provided by⁠ FirstRanker.com ---

Low dose heparin, low molecular weight heparin
Early mobilization
Hydration
T E D stockings
Surgery in patients on

--- Content provided by‍ FirstRanker.com ---


anticoagulants

DRUG

--- Content provided by​ FirstRanker.com ---

BLEEDING

ELECTIVE

EMERGENCY

--- Content provided by​ FirstRanker.com ---


RISK

SURGERY

--- Content provided by⁠ FirstRanker.com ---

SURGERY

1 .HEPARIN Low / Moderate Discontinue high dose Same as elective

Give low dose heparin

--- Content provided by⁠ FirstRanker.com ---


High risk

Discontinue 6 ? 12 hrs Discontinue

--- Content provided by​ FirstRanker.com ---

before surgery

Give Protamine sulphate

2. L M W H -- Discontinue 12 ? 24 hrs before surgery especial y in high risk

--- Content provided by​ FirstRanker.com ---


group



--- Content provided by​ FirstRanker.com ---

Surgery in patients on

anticoagulants

DRUG

--- Content provided by‌ FirstRanker.com ---


BLEEDING ELECTIVE

EMERGENCY

--- Content provided by⁠ FirstRanker.com ---

RISK

SURGERY

SURGERY

--- Content provided by FirstRanker.com ---


3. WarfarinLOW

Adjust dose to I N R < 2.5 Discontinue warfarin

--- Content provided by‍ FirstRanker.com ---

MODERATE `'

Discontinue warfarin


--- Content provided by‍ FirstRanker.com ---


FFP to decrease INR



--- Content provided by⁠ FirstRanker.com ---

to < 2.5.

HIGH

Discontinue & al ow P T to Discontinue warfarin

--- Content provided by FirstRanker.com ---

normalize. Substitute with FFP , Vit K to

heparin .

normalize PT.

--- Content provided by‌ FirstRanker.com ---

Surgery in patients on

anticoagulants

Aspirin:

--- Content provided by⁠ FirstRanker.com ---


Discontinue 1 week before surgery.
Platelet transfusion
DDAVP

--- Content provided by​ FirstRanker.com ---

In emergency surgery

Fibrinolytics:
Wait for half life
6 min for TPA

--- Content provided by‌ FirstRanker.com ---

23 min for Streptokinase
16 min for Urokinase
EACA: Only in emergency.

Weigh benefit Vs risk

--- Content provided by‍ FirstRanker.com ---


CONCLUSION

The more exotic these approaches become, the more one is compelled

--- Content provided by‌ FirstRanker.com ---

to emphasize that gentle handling, precise dissection and accurately

applied haemostasis constitute much the art of surgery.

Injecting, burning, stuffing, and scorching wounds is not likely to lead to

--- Content provided by⁠ FirstRanker.com ---


a higher plateau of accomplishment.

John A Collins , M.D

--- Content provided by​ FirstRanker.com ---